EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 200 filers reported holding EDITAS MEDICINE INC in Q1 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $860,000 | +34.8% | 15,190 | 0.0% | 0.03% | +27.3% |
| Q1 2021 | $638,000 | -83.4% | 15,190 | -88.3% | 0.02% | -85.0% |
| Q2 2020 | $3,851,000 | +49.1% | 130,201 | 0.0% | 0.15% | +25.6% |
| Q1 2020 | $2,582,000 | -41.1% | 130,201 | -12.0% | 0.12% | -29.5% |
| Q4 2019 | $4,380,000 | +30.2% | 147,939 | 0.0% | 0.17% | +12.9% |
| Q3 2019 | $3,364,000 | +202.2% | 147,939 | +228.8% | 0.15% | +226.7% |
| Q2 2019 | $1,113,000 | -40.6% | 44,989 | -41.3% | 0.04% | -40.8% |
| Q1 2019 | $1,875,000 | +7.5% | 76,668 | 0.0% | 0.08% | +1.3% |
| Q4 2018 | $1,744,000 | -28.5% | 76,668 | 0.0% | 0.08% | -14.8% |
| Q3 2018 | $2,440,000 | -50.6% | 76,668 | -44.4% | 0.09% | -52.9% |
| Q2 2018 | $4,937,000 | +8.1% | 137,801 | 0.0% | 0.19% | +5.1% |
| Q1 2018 | $4,568,000 | – | 137,801 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |